A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
The use of functional genomics in primary immune cells has been limited by inefficient vector delivery and risk of perturbing cell states. Here the authors present CHimeric IMmune Editing (CHIME) for in vivo evaluation of gene function and pooled screening approaches.
Saved in:
Main Authors: | Martin W. LaFleur, Thao H. Nguyen, Matthew A. Coxe, Kathleen B. Yates, Justin D. Trombley, Sarah A. Weiss, Flavian D. Brown, Jacob E. Gillis, Daniel J. Coxe, John G. Doench, W. Nicholas Haining, Arlene H. Sharpe |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f4cc26f0a06e487587662b0cfb8d4512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Reverse Transcriptases Associated with CRISPR-Cas Systems
by: Nicolás Toro, et al.
Published: (2017) -
Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting
by: Fuqiang Chen, et al.
Published: (2017) -
CRISPR/Cas System and Factors Affecting Its Precision and Efficiency
by: Nasir Javaid, et al.
Published: (2021) -
Optimization of genome engineering approaches with the CRISPR/Cas9 system.
by: Kai Li, et al.
Published: (2014) -
Virus detection via programmable Type III-A CRISPR-Cas systems
by: Sagar Sridhara, et al.
Published: (2021)